Fatty Liver (MASLD): How Much Weight Loss Reverses It, and What Else Helps
"Fatty liver" is now one of the most common findings on abdominal ultrasound. Worldwide, about 30% of adults have it (Hepatology, 2023). In 2023, liver societies renamed the condition from NAFLD to MASLD, metabolic dysfunction-associated steatotic liver disease (consensus statement). The new name reflects what drives it: excess weight, insulin resistance, type 2 diabetes, high triglycerides and high blood pressure. Its inflamed, more serious form is now called MASH.
Most people with fatty liver never develop serious liver disease. What matters is whether scarring (fibrosis) is building up, because fibrosis is what can lead to cirrhosis and liver cancer. It is also the strongest predictor of outcome.
First steps after the diagnosis
- Rule out other causes. Alcohol, hepatitis B and C, and some medicines can also cause fatty liver or liver damage. Where hepatitis is common, as in Pakistan, which has one of the world's highest rates of hepatitis C, a fatty liver finding should come with hepatitis B and C tests.
- Check for scarring. The FIB-4 score uses age, two liver enzymes (AST and ALT) and the platelet count from routine blood tests. A low score largely rules out advanced fibrosis. A higher or uncertain score leads to a FibroScan, an ultrasound-based stiffness test, or further assessment.
- Check the rest of your metabolism. That means blood sugar, cholesterol and blood pressure. People with fatty liver are more likely to die of heart disease than of liver disease.
Weight loss: the dose–response
Few conditions respond as clearly to weight loss. In a study of 293 people with biopsy-proven fatty liver inflammation, repeat biopsies after a year of lifestyle change showed a clear pattern:
- losing 5% of body weight or more reduced liver fat
- losing 7% or more resolved the inflammation in most people
- among those who lost 10% or more, the inflammation resolved in 90% and scarring improved in 45%
Gradual loss of 0.5 to 1 kg a week is safest. Very rapid weight loss can occasionally worsen liver inflammation and trigger gallstones.

Mediterranean-style eating reduces liver fat even before much weight is lost. Photo: Daniela Elena Tentis / Pexels
What to eat and drink
- Cut sugary drinks and juice. Fructose is turned into fat in the liver more readily than other sugars.
- Mediterranean-style eating, with vegetables, pulses, whole grains, fish, nuts and olive oil, reduces liver fat even before much weight is lost.
- Alcohol: less is better, and none is best if there is any significant fibrosis. When alcohol and metabolic risk factors overlap, the damage adds up.
- Coffee: two to three cups a day is consistently linked with less liver scarring in observational studies. If you already drink it, there is no need to stop.
Exercise
Regular aerobic exercise and resistance training both reduce liver fat, even without weight loss. Aim for at least 150 minutes a week. Exercise also lowers the heart risk that comes with fatty liver.
Medicines
For years there was no approved drug for fatty liver disease. That has changed for people with MASH and moderate to advanced fibrosis.
- Resmetirom, a liver-targeted thyroid hormone receptor drug, was approved in the US in 2024 after a phase 3 trial showed it improved liver inflammation and fibrosis.
- Semaglutide, the weight-loss and diabetes injection, resolved MASH in about 63% of patients compared with 34% on placebo after 72 weeks in a 2025 trial, and improved fibrosis in more patients than placebo did.
- Pioglitazone, a diabetes tablet, and vitamin E are sometimes used by specialists in selected patients. Vitamin E is for people without diabetes, and both have trade-offs.
Statins are safe in fatty liver and should not be avoided out of liver worries. They reduce the main cause of death in these patients, heart disease. Paracetamol at normal doses is also fine.
Be wary of liver "detox" products and herbal supplements. Turmeric extracts, green tea extract, ashwagandha and garcinia have all been linked to cases of liver injury, and none has been shown to treat fatty liver.
See a doctor promptly for
- yellowing of the skin or eyes
- a swollen abdomen
- vomiting blood or passing black stools
- confusion or unusual drowsiness
These are signs of advanced liver disease. The NHS fatty liver guide has more on tests and follow-up.
Sources
- Younossi Z, Golabi P, Paik J, Henry A et al., "The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review", Hepatology 77 (2023): 1335-1347. https://doi.org/10.1097/HEP.0000000000000004
- Rinella M, Lazarus J, Ratziu V, Francque S et al., "A multisociety Delphi consensus statement on new fatty liver disease nomenclature", Hepatology 78 (2023): 1966-1986. https://doi.org/10.1097/HEP.0000000000000520
- Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A et al., "Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis", Gastroenterology 149 (2015): 367-378.e5. https://doi.org/10.1053/j.gastro.2015.04.005
- Harrison S, Bedossa P, Guy C, Schattenberg J et al., "A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis", New England Journal of Medicine 390 (2024): 497-509. https://doi.org/10.1056/NEJMoa2309000
- Sanyal A, Newsome P, Kliers I, Østergaard L et al., "Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis", New England Journal of Medicine 392 (2025): 2089-2099. https://doi.org/10.1056/NEJMoa2413258
- NHS, "Non-alcoholic fatty liver disease (NAFLD)". https://www.nhs.uk/conditions/non-alcoholic-fatty-liver-disease/
Comments (0)
Leave a Reply
Comments are moderated. Please read our Comment Policy before posting.
Log in to post a comment.